Next Article in Journal
Antifungal Resistance in Candida auris: Molecular Determinants
Next Article in Special Issue
Single Cell Analysis of Drug Susceptibility of Mycobacterium abscessus during Macrophage Infection
Previous Article in Journal
Synergy of the Bacteriocin AS-48 and Antibiotics against Uropathogenic Enterococci
Previous Article in Special Issue
Genetic Identification and Drug-Resistance Characterization of Mycobacterium tuberculosis Using a Portable Sequencing Device. A Pilot Study
Review

Mycogenic Metal Nanoparticles for the Treatment of Mycobacterioses

1
State Key Laboratory of Lunar and Planetary Sciences, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau SAR, China
2
Bioscience Institute, São Paulo State University (UNESP), São Vicente, SP 11380-972, Brazil
*
Author to whom correspondence should be addressed.
Antibiotics 2020, 9(9), 569; https://doi.org/10.3390/antibiotics9090569
Received: 30 June 2020 / Revised: 31 August 2020 / Accepted: 31 August 2020 / Published: 2 September 2020
(This article belongs to the Special Issue Mycobacterial Infections and Therapy)
Mycobacterial infections are a resurgent and increasingly relevant problem. Within these, tuberculosis (TB) is particularly worrying as it is one of the top ten causes of death in the world and is the infectious disease that causes the highest number of deaths. A further concern is the on-going emergence of antimicrobial resistance, which seriously limits treatment. The COVID-19 pandemic has worsened current circumstances and future infections will be more incident. It is urgent to plan, draw solutions, and act to mitigate these issues, namely by exploring new approaches. The aims of this review are to showcase the extensive research and application of silver nanoparticles (AgNPs) and other metal nanoparticles (MNPs) as antimicrobial agents. We highlight the advantages of mycogenic synthesis, and report on their underexplored potential as agents in the fight against all mycobacterioses (non-tuberculous mycobacterial infections as well as TB). We propose further exploration of this field. View Full-Text
Keywords: metal nanoparticles (MNP); silver nanoparticles (AgNP); filamentous fungi; mycogenic synthesis; tuberculosis (TB); Mycobacterium tuberculosis (MTb); nontuberculous mycobacteria (NTM) metal nanoparticles (MNP); silver nanoparticles (AgNP); filamentous fungi; mycogenic synthesis; tuberculosis (TB); Mycobacterium tuberculosis (MTb); nontuberculous mycobacteria (NTM)
Show Figures

Figure 1

MDPI and ACS Style

Simões, M.F.; Ottoni, C.A.; Antunes, A. Mycogenic Metal Nanoparticles for the Treatment of Mycobacterioses. Antibiotics 2020, 9, 569. https://doi.org/10.3390/antibiotics9090569

AMA Style

Simões MF, Ottoni CA, Antunes A. Mycogenic Metal Nanoparticles for the Treatment of Mycobacterioses. Antibiotics. 2020; 9(9):569. https://doi.org/10.3390/antibiotics9090569

Chicago/Turabian Style

Simões, Marta F., Cristiane A. Ottoni, and André Antunes. 2020. "Mycogenic Metal Nanoparticles for the Treatment of Mycobacterioses" Antibiotics 9, no. 9: 569. https://doi.org/10.3390/antibiotics9090569

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop